Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-04-07
Madaus Martin D Files Hologic (HOLX) Form 4 - April 07, 2026
Madaus Martin D sold 10.8K HOLX shares in this Form 4 filing, reported to the SEC on 2026-04-07.
- Insider
- Madaus Martin D
- Issuer
- Hologic Inc. HOLX · NASDAQ
- Filed
- Period
- 2026-04-07
- Accession
- 0000859737-26-000067
- Source
- Official filing on sec.gov ↗
Transactions (2)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Madaus Martin D | 2026-04-07 | Sell | 5.4K | - | $0.00 | Direct |
| Madaus Martin D | 2026-04-07 | Sell | 5.4K | - | $0.00 | Indirect |
| Net change | −10.8K | $0.00 | ||||
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Track HOLX insider activity
Get alerted when Hologic Inc. executives buy or sell their shares.